3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide

C26H30BrClN4O3S2 — CID 23030557

IUPAC3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide
SMILESO=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1ccc(OCCO)c(Br)c1
InChIInChI=1S/C26H30BrClN4O3S2/c27-20-14-17(6-7-21(20)35-13-12-33)24(34)30-26-29-23(22-15-18(28)16-36-22)25(37-26)32-10-8-31(9-11-32)19-4-2-1-3-5-19/h6-7,14-16,19,33H,1-5,8-13H2,(H,29,30,34)
InChIKeyOINYHPLPKASPLN-UHFFFAOYSA-N
MW626.04 g/mol
LogP6.37
Rot. Bonds8

About 3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide

3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide (PubChem CID 23030557) has the molecular formula C26H30BrClN4O3S2 and a molecular weight of 626.04 g/mol. Its IUPAC name is 3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide.

Molecular Properties

Compound Name3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide
PubChem CID23030557
Molecular FormulaC26H30BrClN4O3S2
Molecular Weight626.04 g/mol
Exact Mass624.06
IUPAC Name3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide
SMILESO=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1ccc(OCCO)c(Br)c1
InChIInChI=1S/C26H30BrClN4O3S2/c27-20-14-17(6-7-21(20)35-13-12-33)24(34)30-26-29-23(22-15-18(28)16-36-22)25(37-26)32-10-8-31(9-11-32)19-4-2-1-3-5-19/h6-7,14-16,19,33H,1-5,8-13H2,(H,29,30,34)
InChIKeyOINYHPLPKASPLN-UHFFFAOYSA-N
XLogP6.37
TPSA77.93 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms37
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500626.04
LogP ≤ 56.37
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze 3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide?
The IUPAC name of 3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide (CID 23030557) is 3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide.
What is the SMILES notation for 3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide?
The canonical SMILES for 3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide is O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1ccc(OCCO)c(Br)c1.
What is the InChIKey of 3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide?
The InChIKey is OINYHPLPKASPLN-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H30BrClN4O3S2/c27-20-14-17(6-7-21(20)35-13-12-33)24(34)30-26-29-23(22-15-18(28)16-36-22)25(37-26)32-10-8-31(9-11-32)19-4-2-1-3-5-19/h6-7,14-16,19,33H,1-5,8-13H2,(H,29,30,34).
What are the key properties of 3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide?
3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide has a molecular weight of 626.04 g/mol, XLogP of 6.37, 8 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromo-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-4-(2-hydroxyethoxy)benzamide is sourced from PubChem (CID 23030557), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).